"This is a big moment for us," says George Archos, CEO of Verano Holdings Corp (CSE: VRNO)(OTCQX: VRNOF), in light of the recent announcement where the Department of Health and Human Services (HHS) recommended the Drug Enforcement Administration (DEA) to reclassify cannabis from a Schedule I to a Schedule III substance.

The monumental recommendation by HHS could transform the landscape of the cannabis industry.

Benzinga’s cannabis editor Maureen Meehan interviewed Archos to gauge the pulse of the industry. "Something we've been waiting for. When President Biden ordered something here, we thought it would take a really long amount of time. But this is a big positive moment for cannabis as an industry as a whole."

Want to talk with the team of this leading, vertically integrated, U.S. multi-state cannabis company? Darren Weiss Verano’s president and Aaron Miles CIO at …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.